NEBA Health has secured FDA approval for its Neuropsychiatric EEG-Based Assessment Aid System. The test uses brain waves to help identify the presence of attention-deficit/hyperactivity disorder in children younger than 18.
FDA approves first brain-wave device for ADHD detection
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||